Show notes
In today’s Ask Me Anything episode, Ken and Dawn answer a wide range of questions that cover:A recent FDA approval of a neural implant device for people with degenerative neuromuscular disease or spinal-cord injuries.Global security in the age of AI.A study that looked at ways to optimize glymphatic clearance for people with acute or chronic sleep deprivation.Why more gyms don’t offer blood-flow restriction classes for their clients.Developments in the realm of Generative AI.The tradeoffs between a low-carb diet versus a ketogenic diet.A study on Alzheimer’s titled, “APOE 4 Homozygosity Represents a Distinct Genetic Form of Alzheimer’s Disease.”Plus, Ken reveals his favorite science-fiction author.[[[00:08:48] Multiple listeners ask Ken about a paper recently published titled: “APOE 4 Homozygosity Represents a Distinct Genetic Form of Alzheimer’s Disease.” Listeners ask if it is true that people with two copies of APOE4 allele are certain to develop the disease.[00:19:30] A listener asks Ken about his time on the National Security Commission on Artificial Intelligence. The commission issued its report five years ago with specific recommendations on how the government should prepare for and defend against the national security implications of AI. Ken shares his thoughts on the implementation of the commission’s recommendations.[[00:27:10] A listener asks Ken why more gyms and physical therapy centers don’t have blood flow restriction devices (BFR) available for their clientele, given that studies have shown that BFR improves strength and muscle mass in both young and older adults. (Two STEM-Talk episodes that cover blood-flow restriction include episode 34 and episode 161.[[[[[Links:Learn more about IHMCSTEM-Talk homepageKen Ford bioKen Ford Wikipedia pageDawn Kernagis bio



